Turn Therapeutics Inc. TTRX
We take great care to ensure that the data presented and summarized in this overview for Turn Therapeutics Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in TTRX
Top Purchases
Top Sells
About TTRX
Insider Transactions at TTRX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 08
2025
|
Andrew Gengos Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 08
2025
|
Arthur F Golden Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 08
2025
|
Kent Edward Kester Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
|
Oct 08
2025
|
Neilesh Shailesh Ghodadra Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
40K
Shares
From
4
Insiders
| Grant, award, or other acquisition | 40K shares |
|---|
Sell / Disposition
0
Shares
From
0
Insiders